Valencell

Valencell transforms the science of wearable biometrics to enable impactful health outcomes. Through innovative R&D and validated technologies, we develop breakthroughs and collaborate with wearables, hearables, and medical device companies around the world to deliver amazing results. With more than 85 granted patents and 100+ patents pending around the world, Valencell’s technology continuously and accurately measures real-time biometric and physiological data that powers meaningful consumer and patient insights. Founded: Founded in 2006 and headquartered in Raleigh, North Carolina Investors: Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund Leadership Kent Novak, Chairman, CEO Steven LeBoeuf, Ph.D., Founder & President Michael Aumer, Ph.D., VP of R&D Kristine O'Shea, VP of Finance Mark Felice, VP of Business Development and Licensing Ryan Kraudel, VP of Marketing Chris Eschbach, Ph.D., HFS, CSCS, Exercise Physiologist 4601 Six Forks Road Suite 103 Raleigh, NC 27609 919-747-3668 / [email protected] / www.valencell.com